

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.37732423 |
| 2 | central nervous system myelination (GO:0022010) | 7.37732423 |
| 3 | fatty acid elongation (GO:0030497) | 4.75344879 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.66491997 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.66491997 |
| 6 | glycerophospholipid catabolic process (GO:0046475) | 4.23766796 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.18749094 |
| 8 | axon ensheathment (GO:0008366) | 4.03774043 |
| 9 | ensheathment of neurons (GO:0007272) | 4.03774043 |
| 10 | myelination (GO:0042552) | 4.01410539 |
| 11 | myelin maintenance (GO:0043217) | 3.97842850 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 3.96915357 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.96915357 |
| 14 | neurotransmitter uptake (GO:0001504) | 3.93246452 |
| 15 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.88180663 |
| 16 | epithelial cilium movement (GO:0003351) | 3.60628549 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.59352093 |
| 18 | microglial cell activation (GO:0001774) | 3.51511711 |
| 19 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.48029537 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.42648456 |
| 21 | response to methylmercury (GO:0051597) | 3.42138225 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39861643 |
| 23 | nucleobase catabolic process (GO:0046113) | 3.39051724 |
| 24 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.34289674 |
| 25 | C4-dicarboxylate transport (GO:0015740) | 3.28965257 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26258810 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 3.25429320 |
| 28 | auditory behavior (GO:0031223) | 3.20069133 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 3.19616020 |
| 30 | regulation of cilium movement (GO:0003352) | 3.16163884 |
| 31 | postsynaptic membrane organization (GO:0001941) | 3.15785205 |
| 32 | locomotory exploration behavior (GO:0035641) | 3.14627906 |
| 33 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.13078052 |
| 34 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.11992526 |
| 35 | cilium movement (GO:0003341) | 3.10904461 |
| 36 | photoreceptor cell differentiation (GO:0046530) | 3.07967036 |
| 37 | eye photoreceptor cell differentiation (GO:0001754) | 3.07967036 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 3.06987383 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 3.06745486 |
| 40 | apical protein localization (GO:0045176) | 3.05879182 |
| 41 | axonemal dynein complex assembly (GO:0070286) | 3.04574797 |
| 42 | regulation of lipoprotein metabolic process (GO:0050746) | 3.03078904 |
| 43 | response to lipoprotein particle (GO:0055094) | 3.01195465 |
| 44 | alpha-linolenic acid metabolic process (GO:0036109) | 2.99823718 |
| 45 | response to redox state (GO:0051775) | 2.99595262 |
| 46 | cholesterol biosynthetic process (GO:0006695) | 2.96812035 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 2.94953140 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 2.93397802 |
| 49 | cell wall macromolecule catabolic process (GO:0016998) | 2.91898539 |
| 50 | very long-chain fatty acid metabolic process (GO:0000038) | 2.91311748 |
| 51 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.89520574 |
| 52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.88187029 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 2.85209958 |
| 54 | L-amino acid import (GO:0043092) | 2.83319214 |
| 55 | oligodendrocyte differentiation (GO:0048709) | 2.83287736 |
| 56 | asymmetric protein localization (GO:0008105) | 2.83277069 |
| 57 | regulation of pigment cell differentiation (GO:0050932) | 2.81915407 |
| 58 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.81738302 |
| 59 | cellular response to leptin stimulus (GO:0044320) | 2.80624772 |
| 60 | regulation of cell communication by electrical coupling (GO:0010649) | 2.80498624 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.80039039 |
| 62 | glutamate secretion (GO:0014047) | 2.79754221 |
| 63 | macroautophagy (GO:0016236) | 2.79272231 |
| 64 | creatine metabolic process (GO:0006600) | 2.77935072 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 2.77291899 |
| 66 | response to dietary excess (GO:0002021) | 2.76771235 |
| 67 | protein localization to cilium (GO:0061512) | 2.72251659 |
| 68 | vocalization behavior (GO:0071625) | 2.71989302 |
| 69 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.70545780 |
| 70 | nonmotile primary cilium assembly (GO:0035058) | 2.69336357 |
| 71 | magnesium ion transport (GO:0015693) | 2.68024766 |
| 72 | cell wall macromolecule metabolic process (GO:0044036) | 2.67717056 |
| 73 | gamma-aminobutyric acid transport (GO:0015812) | 2.67426609 |
| 74 | regulation of relaxation of muscle (GO:1901077) | 2.66646767 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 2.66627957 |
| 76 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.66283029 |
| 77 | glycine transport (GO:0015816) | 2.64017423 |
| 78 | detection of calcium ion (GO:0005513) | 2.63174170 |
| 79 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.61797766 |
| 80 | Golgi to endosome transport (GO:0006895) | 2.61756529 |
| 81 | neural tube formation (GO:0001841) | 2.61657079 |
| 82 | sterol biosynthetic process (GO:0016126) | 2.61152011 |
| 83 | neutrophil mediated immunity (GO:0002446) | 2.58226479 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.58178113 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 2.58109670 |
| 86 | neuron-neuron synaptic transmission (GO:0007270) | 2.57000013 |
| 87 | exploration behavior (GO:0035640) | 2.56912007 |
| 88 | regulation of beta-amyloid formation (GO:1902003) | 2.56658868 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 2.55203902 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.55035142 |
| 91 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.54525066 |
| 92 | import into cell (GO:0098657) | 2.53955543 |
| 93 | amyloid precursor protein metabolic process (GO:0042982) | 2.53467257 |
| 94 | platelet dense granule organization (GO:0060155) | 2.52918984 |
| 95 | synaptic transmission, glutamatergic (GO:0035249) | 2.52868441 |
| 96 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.52832477 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52824215 |
| 98 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.52754131 |
| 99 | protein localization to synapse (GO:0035418) | 2.52482880 |
| 100 | mechanosensory behavior (GO:0007638) | 2.52007292 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.51644593 |
| 102 | protein localization to endosome (GO:0036010) | 2.51405014 |
| 103 | response to leptin (GO:0044321) | 2.50950699 |
| 104 | response to auditory stimulus (GO:0010996) | 2.50273872 |
| 105 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.49492175 |
| 106 | positive regulation of microtubule polymerization (GO:0031116) | 2.48450211 |
| 107 | regulation of coenzyme metabolic process (GO:0051196) | 2.48158938 |
| 108 | regulation of cofactor metabolic process (GO:0051193) | 2.48158938 |
| 109 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.47659649 |
| 110 | bile acid biosynthetic process (GO:0006699) | 2.47319458 |
| 111 | cilium morphogenesis (GO:0060271) | 2.47268419 |
| 112 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.47053257 |
| 113 | anterograde synaptic vesicle transport (GO:0048490) | 2.46810088 |
| 114 | protein targeting to Golgi (GO:0000042) | 2.46786961 |
| 115 | regulation of collateral sprouting (GO:0048670) | 2.45808189 |
| 116 | thioester biosynthetic process (GO:0035384) | 2.45423891 |
| 117 | acyl-CoA biosynthetic process (GO:0071616) | 2.45423891 |
| 118 | negative regulation of protein localization to cell surface (GO:2000009) | 2.45266671 |
| 119 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.45033950 |
| 120 | growth hormone receptor signaling pathway (GO:0060396) | 2.44997097 |
| 121 | complement activation, alternative pathway (GO:0006957) | 2.44912800 |
| 122 | intraciliary transport (GO:0042073) | 2.44790668 |
| 123 | negative regulation of adenylate cyclase activity (GO:0007194) | 2.43561025 |
| 124 | negative regulation of response to food (GO:0032096) | 2.43405763 |
| 125 | negative regulation of appetite (GO:0032099) | 2.43405763 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.42773042 |
| 127 | amino acid import (GO:0043090) | 2.42682145 |
| 128 | neuron fate determination (GO:0048664) | 2.42559367 |
| 129 | righting reflex (GO:0060013) | 2.41668594 |
| 130 | presynaptic membrane organization (GO:0097090) | 2.39926679 |
| 131 | regulation of protein glycosylation (GO:0060049) | 2.39453653 |
| 132 | tyrosine metabolic process (GO:0006570) | 2.39022218 |
| 133 | glycerolipid catabolic process (GO:0046503) | 2.38774881 |
| 134 | regulation of neurotransmitter uptake (GO:0051580) | 2.38716476 |
| 135 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.38136988 |
| 136 | type B pancreatic cell development (GO:0003323) | 2.37945897 |
| 137 | neutrophil activation involved in immune response (GO:0002283) | 2.37033677 |
| 138 | proline transport (GO:0015824) | 2.36442718 |
| 139 | relaxation of smooth muscle (GO:0044557) | 2.36431319 |
| 140 | regulation of sulfur metabolic process (GO:0042762) | 2.36339844 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.36198468 |
| 142 | membrane tubulation (GO:0097320) | 2.35942887 |
| 143 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.35468569 |
| 144 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.35183722 |
| 145 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.34763095 |
| 146 | acidic amino acid transport (GO:0015800) | 2.34758101 |
| 147 | ketone body metabolic process (GO:1902224) | 2.34309589 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 2.34308502 |
| 149 | neurotransmitter secretion (GO:0007269) | 2.34225314 |
| 150 | behavioral response to cocaine (GO:0048148) | 2.33756719 |
| 151 | neuronal action potential propagation (GO:0019227) | 2.33678612 |
| 152 | negative regulation of cyclase activity (GO:0031280) | 2.33465818 |
| 153 | cysteine metabolic process (GO:0006534) | 2.32518782 |
| 154 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.32025263 |
| 155 | bile acid metabolic process (GO:0008206) | 2.31931287 |
| 156 | coenzyme catabolic process (GO:0009109) | 2.31124724 |
| 157 | regulation of bile acid biosynthetic process (GO:0070857) | 2.30018915 |
| 158 | adult walking behavior (GO:0007628) | 2.29789610 |
| 159 | peripheral nervous system axon ensheathment (GO:0032292) | 2.29352584 |
| 160 | myelination in peripheral nervous system (GO:0022011) | 2.29352584 |
| 161 | dicarboxylic acid catabolic process (GO:0043649) | 2.27520418 |
| 162 | axon development (GO:0061564) | 2.26529471 |
| 163 | peroxisome fission (GO:0016559) | 2.25586067 |
| 164 | presynaptic membrane assembly (GO:0097105) | 2.23346718 |
| 165 | ER overload response (GO:0006983) | 2.22589045 |
| 166 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.22523993 |
| 167 | sphingosine metabolic process (GO:0006670) | 2.20704082 |
| 168 | cholesterol efflux (GO:0033344) | 2.19855787 |
| 169 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.18155167 |
| 170 | peroxisome organization (GO:0007031) | 2.16307385 |
| 171 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.15540686 |
| 172 | acylglycerol biosynthetic process (GO:0046463) | 2.15293920 |
| 173 | neutral lipid biosynthetic process (GO:0046460) | 2.15293920 |
| 174 | regulation of cholesterol metabolic process (GO:0090181) | 2.14874889 |
| 175 | neuron remodeling (GO:0016322) | 2.12812907 |
| 176 | regulation of ARF protein signal transduction (GO:0032012) | 2.12507377 |
| 177 | triglyceride biosynthetic process (GO:0019432) | 2.12379625 |
| 178 | prostate gland growth (GO:0060736) | 2.12300275 |
| 179 | cholesterol metabolic process (GO:0008203) | 2.12138341 |
| 180 | cellular response to growth hormone stimulus (GO:0071378) | 2.10475255 |
| 181 | endocrine pancreas development (GO:0031018) | 2.10356160 |
| 182 | regulation of autophagic vacuole assembly (GO:2000785) | 2.08937805 |
| 183 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.08581004 |
| 184 | cofactor catabolic process (GO:0051187) | 2.08470477 |
| 185 | glycosylceramide metabolic process (GO:0006677) | 2.07633587 |
| 186 | negative regulation of inclusion body assembly (GO:0090084) | 2.07574363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.76418915 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25674203 |
| 3 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.10662624 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08389157 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96902489 |
| 6 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.94134222 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92395732 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.90806263 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87674387 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83503106 |
| 11 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81221661 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80427303 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79844271 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79644814 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76952079 |
| 16 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.71407853 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66644407 |
| 18 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61505487 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61396907 |
| 20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56734326 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55249887 |
| 22 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54896013 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50550191 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49751627 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49074764 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47837935 |
| 27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47367920 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.46192704 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.46009957 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45761202 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.45340735 |
| 32 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45134479 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44280420 |
| 34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42553697 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42464671 |
| 36 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42248534 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42003287 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41291840 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41197226 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41197226 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40672064 |
| 42 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37850143 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37560644 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35008742 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34617008 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33187046 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32763827 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31857369 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.30829783 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29915443 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29041550 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28994307 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27842671 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27321886 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26001493 |
| 56 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25607526 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24773581 |
| 58 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24603925 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24603925 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24169183 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23801760 |
| 62 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.22019496 |
| 63 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21482516 |
| 64 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21482516 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21318070 |
| 66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.21243703 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21223968 |
| 68 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20674073 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20661686 |
| 70 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.20422799 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19506643 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17153742 |
| 73 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.16963114 |
| 74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16835760 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16509023 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16505115 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16031099 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15048042 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14744363 |
| 80 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14273245 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13778805 |
| 82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13701525 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13451363 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13451363 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13095094 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12905831 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12863586 |
| 88 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12718769 |
| 89 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12718769 |
| 90 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12331446 |
| 91 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12316652 |
| 92 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.11532002 |
| 93 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.11178162 |
| 94 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11006902 |
| 95 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10703026 |
| 96 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10603939 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10522054 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10058631 |
| 99 | * JUN_21703547_ChIP-Seq_K562_Human | 1.09807184 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08493333 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08418640 |
| 102 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08130349 |
| 103 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07975050 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07476517 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07258995 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07180030 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06555821 |
| 108 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06549669 |
| 109 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06477041 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06388901 |
| 111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06222888 |
| 112 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05680370 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05467797 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05065896 |
| 115 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04622917 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04534519 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03335491 |
| 118 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.03104482 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02937097 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02595424 |
| 121 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02515567 |
| 122 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.02409502 |
| 123 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02175253 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02123660 |
| 125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01869179 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01320133 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00644480 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00614694 |
| 129 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00606041 |
| 130 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00029129 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00006811 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99768572 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99459078 |
| 134 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98931390 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98783847 |
| 136 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98762466 |
| 137 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98724718 |
| 138 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98452594 |
| 139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97960724 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97832252 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97740927 |
| 142 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97042167 |
| 143 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96708888 |
| 144 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96576222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.30001055 |
| 2 | MP0000920_abnormal_myelination | 3.70486466 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.57049365 |
| 4 | MP0004270_analgesia | 3.25206002 |
| 5 | MP0003329_amyloid_beta_deposits | 3.08911466 |
| 6 | MP0005451_abnormal_body_composition | 2.98918077 |
| 7 | MP0005365_abnormal_bile_salt | 2.98151678 |
| 8 | MP0003690_abnormal_glial_cell | 2.86129942 |
| 9 | MP0005360_urolithiasis | 2.84132230 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.49325479 |
| 11 | MP0003724_increased_susceptibility_to | 2.47494320 |
| 12 | MP0002638_abnormal_pupillary_reflex | 2.39490347 |
| 13 | MP0005248_abnormal_Harderian_gland | 2.39455308 |
| 14 | MP0001984_abnormal_olfaction | 2.38168644 |
| 15 | MP0009840_abnormal_foam_cell | 2.34119860 |
| 16 | MP0005408_hypopigmentation | 2.27122171 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.26879773 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.18743908 |
| 19 | MP0000604_amyloidosis | 2.08732507 |
| 20 | MP0000462_abnormal_digestive_system | 2.05220708 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.03187986 |
| 22 | MP0001529_abnormal_vocalization | 1.97052207 |
| 23 | MP0003195_calcinosis | 1.96008046 |
| 24 | MP0003252_abnormal_bile_duct | 1.95067972 |
| 25 | MP0004043_abnormal_pH_regulation | 1.94229947 |
| 26 | MP0004885_abnormal_endolymph | 1.92171856 |
| 27 | MP0003880_abnormal_central_pattern | 1.87589811 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.83013888 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.82740118 |
| 30 | MP0003011_delayed_dark_adaptation | 1.81218479 |
| 31 | MP0003634_abnormal_glial_cell | 1.79898807 |
| 32 | MP0004859_abnormal_synaptic_plasticity | 1.78841968 |
| 33 | MP0003632_abnormal_nervous_system | 1.78760369 |
| 34 | MP0001486_abnormal_startle_reflex | 1.78668214 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.75163896 |
| 36 | MP0000427_abnormal_hair_cycle | 1.69026145 |
| 37 | MP0003868_abnormal_feces_composition | 1.68405771 |
| 38 | MP0008260_abnormal_autophagy | 1.64214467 |
| 39 | MP0002736_abnormal_nociception_after | 1.63434053 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.61428152 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.61304374 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.61006837 |
| 43 | MP0003136_yellow_coat_color | 1.60385933 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.56684560 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.56566524 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.55591699 |
| 47 | MP0002272_abnormal_nervous_system | 1.53651666 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.52380175 |
| 49 | MP0005253_abnormal_eye_physiology | 1.51680672 |
| 50 | MP0004484_altered_response_of | 1.50402231 |
| 51 | MP0003631_nervous_system_phenotype | 1.49310525 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.49297959 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.48089903 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.46889361 |
| 55 | MP0003633_abnormal_nervous_system | 1.42964523 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.42832348 |
| 57 | MP0000639_abnormal_adrenal_gland | 1.41553386 |
| 58 | MP0002229_neurodegeneration | 1.41506675 |
| 59 | MP0003828_pulmonary_edema | 1.41086309 |
| 60 | MP0006276_abnormal_autonomic_nervous | 1.40323225 |
| 61 | MP0003635_abnormal_synaptic_transmissio | 1.39962814 |
| 62 | MP0004883_abnormal_blood_vessel | 1.39313043 |
| 63 | MP0003787_abnormal_imprinting | 1.39040349 |
| 64 | MP0000778_abnormal_nervous_system | 1.37703236 |
| 65 | MP0002064_seizures | 1.32871667 |
| 66 | MP0000579_abnormal_nail_morphology | 1.31728437 |
| 67 | MP0001188_hyperpigmentation | 1.31230345 |
| 68 | MP0001905_abnormal_dopamine_level | 1.30394975 |
| 69 | MP0005423_abnormal_somatic_nervous | 1.25493812 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.25360130 |
| 71 | MP0002822_catalepsy | 1.24438326 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.24030570 |
| 73 | MP0005410_abnormal_fertilization | 1.23333417 |
| 74 | MP0004742_abnormal_vestibular_system | 1.20580934 |
| 75 | MP0001440_abnormal_grooming_behavior | 1.19998427 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.17157390 |
| 77 | MP0002928_abnormal_bile_duct | 1.16747072 |
| 78 | MP0001661_extended_life_span | 1.16281383 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 1.14262367 |
| 80 | MP0005332_abnormal_amino_acid | 1.12875839 |
| 81 | MP0002735_abnormal_chemical_nociception | 1.12550047 |
| 82 | MP0009379_abnormal_foot_pigmentation | 1.12419104 |
| 83 | MP0001346_abnormal_lacrimal_gland | 1.12114174 |
| 84 | MP0005058_abnormal_lysosome_morphology | 1.11773982 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 1.11683728 |
| 86 | MP0008569_lethality_at_weaning | 1.10541060 |
| 87 | MP0001177_atelectasis | 1.09606332 |
| 88 | MP0005386_behavior/neurological_phenoty | 1.08250557 |
| 89 | MP0004924_abnormal_behavior | 1.08250557 |
| 90 | MP0000566_synostosis | 1.08173071 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.08103873 |
| 92 | MP0005083_abnormal_biliary_tract | 1.08009502 |
| 93 | MP0002063_abnormal_learning/memory/cond | 1.07322778 |
| 94 | MP0000955_abnormal_spinal_cord | 1.05355643 |
| 95 | MP0002090_abnormal_vision | 1.05213013 |
| 96 | MP0001502_abnormal_circadian_rhythm | 1.03878258 |
| 97 | MP0000383_abnormal_hair_follicle | 1.02798515 |
| 98 | MP0004142_abnormal_muscle_tone | 1.02609557 |
| 99 | MP0004811_abnormal_neuron_physiology | 1.02442250 |
| 100 | MP0004147_increased_porphyrin_level | 1.00869129 |
| 101 | MP0002909_abnormal_adrenal_gland | 1.00840919 |
| 102 | MP0001851_eye_inflammation | 0.97723568 |
| 103 | MP0000749_muscle_degeneration | 0.97423970 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.96342322 |
| 105 | MP0001970_abnormal_pain_threshold | 0.95093734 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.94949157 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.94928516 |
| 108 | MP0002733_abnormal_thermal_nociception | 0.93688015 |
| 109 | MP0000647_abnormal_sebaceous_gland | 0.93651625 |
| 110 | MP0009745_abnormal_behavioral_response | 0.92953857 |
| 111 | MP0005171_absent_coat_pigmentation | 0.92276965 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 0.92243499 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.91759205 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.91407832 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.90434086 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.89784188 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.89244639 |
| 118 | MP0002133_abnormal_respiratory_system | 0.88920048 |
| 119 | MP0005388_respiratory_system_phenotype | 0.88920048 |
| 120 | MP0005310_abnormal_salivary_gland | 0.88873398 |
| 121 | MP0009046_muscle_twitch | 0.88475274 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.88011861 |
| 123 | MP0002102_abnormal_ear_morphology | 0.87069218 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.86911605 |
| 125 | MP0000609_abnormal_liver_physiology | 0.83663786 |
| 126 | MP0005535_abnormal_body_temperature | 0.83498478 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.83383200 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.82677690 |
| 129 | MP0005647_abnormal_sex_gland | 0.81777998 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81710481 |
| 131 | MP0004130_abnormal_muscle_cell | 0.81658252 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.81382675 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.80450203 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.80221844 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.79994120 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.78464334 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.77921183 |
| 138 | MP0003718_maternal_effect | 0.77817739 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77788708 |
| 140 | MP0002653_abnormal_ependyma_morphology | 0.77644683 |
| 141 | MP0002693_abnormal_pancreas_physiology | 0.76781340 |
| 142 | MP0005187_abnormal_penis_morphology | 0.76633321 |
| 143 | MP0001324_abnormal_eye_pigmentation | 0.76018689 |
| 144 | MP0008877_abnormal_DNA_methylation | 0.75938386 |
| 145 | MP0010386_abnormal_urinary_bladder | 0.75752918 |
| 146 | MP0005195_abnormal_posterior_eye | 0.74487479 |
| 147 | MP0000026_abnormal_inner_ear | 0.72464492 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.69706255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.22489426 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.75066388 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.70136602 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.70136602 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 4.68228879 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 3.98283029 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.90210347 |
| 8 | Gait imbalance (HP:0002141) | 3.75289139 |
| 9 | Insidious onset (HP:0003587) | 3.71596957 |
| 10 | Termporal pattern (HP:0011008) | 3.71596957 |
| 11 | True hermaphroditism (HP:0010459) | 3.68091133 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.66729146 |
| 13 | Onion bulb formation (HP:0003383) | 3.53066152 |
| 14 | Medial flaring of the eyebrow (HP:0010747) | 3.49685038 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 3.45592772 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.45592772 |
| 17 | Congenital primary aphakia (HP:0007707) | 3.41457375 |
| 18 | Sensory axonal neuropathy (HP:0003390) | 3.40883708 |
| 19 | Peripheral hypomyelination (HP:0007182) | 3.38875653 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.34104832 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.33069693 |
| 22 | Pancreatic cysts (HP:0001737) | 3.30437548 |
| 23 | Nephrogenic diabetes insipidus (HP:0009806) | 3.18845084 |
| 24 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.17386115 |
| 25 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.14792134 |
| 26 | Spastic gait (HP:0002064) | 3.06218884 |
| 27 | Xanthomatosis (HP:0000991) | 3.05721853 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.01458138 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.01458138 |
| 30 | Abnormal auditory evoked potentials (HP:0006958) | 2.99919673 |
| 31 | Spastic tetraparesis (HP:0001285) | 2.98902479 |
| 32 | Cerebral hemorrhage (HP:0001342) | 2.97086916 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.96445221 |
| 34 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.94312809 |
| 35 | Hypoglycemic seizures (HP:0002173) | 2.89500202 |
| 36 | Abnormal ciliary motility (HP:0012262) | 2.88358301 |
| 37 | Epidermoid cyst (HP:0200040) | 2.86474690 |
| 38 | Hemiplegia (HP:0002301) | 2.79408458 |
| 39 | Complement deficiency (HP:0004431) | 2.79079632 |
| 40 | Parakeratosis (HP:0001036) | 2.77776711 |
| 41 | Intention tremor (HP:0002080) | 2.77601922 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.76895252 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.66762881 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.63957458 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.63957458 |
| 46 | Dysmetria (HP:0001310) | 2.62063707 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.61092494 |
| 48 | Vaginal atresia (HP:0000148) | 2.60393861 |
| 49 | Peripheral demyelination (HP:0011096) | 2.59076904 |
| 50 | Febrile seizures (HP:0002373) | 2.58890581 |
| 51 | Genital tract atresia (HP:0001827) | 2.58720729 |
| 52 | Chronic hepatic failure (HP:0100626) | 2.56676400 |
| 53 | Myokymia (HP:0002411) | 2.54287033 |
| 54 | Papillary thyroid carcinoma (HP:0002895) | 2.54017207 |
| 55 | Exercise-induced muscle cramps (HP:0003710) | 2.52816847 |
| 56 | Polyphagia (HP:0002591) | 2.47736645 |
| 57 | Rhinitis (HP:0012384) | 2.46019122 |
| 58 | Nephronophthisis (HP:0000090) | 2.43994131 |
| 59 | Abnormality of the axillary hair (HP:0100134) | 2.42716057 |
| 60 | Abnormality of secondary sexual hair (HP:0009888) | 2.42716057 |
| 61 | Thickened helices (HP:0000391) | 2.40046224 |
| 62 | Ankle clonus (HP:0011448) | 2.39741495 |
| 63 | Atonic seizures (HP:0010819) | 2.37457860 |
| 64 | Decreased central vision (HP:0007663) | 2.37114290 |
| 65 | Slow saccadic eye movements (HP:0000514) | 2.36746590 |
| 66 | Paraparesis (HP:0002385) | 2.34399790 |
| 67 | Specific learning disability (HP:0001328) | 2.31136433 |
| 68 | Fat malabsorption (HP:0002630) | 2.28419691 |
| 69 | Abnormality of methionine metabolism (HP:0010901) | 2.28005245 |
| 70 | Spastic paraparesis (HP:0002313) | 2.27526509 |
| 71 | Action tremor (HP:0002345) | 2.27049370 |
| 72 | Furrowed tongue (HP:0000221) | 2.23678728 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22532884 |
| 74 | Split foot (HP:0001839) | 2.22387353 |
| 75 | Ketosis (HP:0001946) | 2.21993864 |
| 76 | Focal seizures (HP:0007359) | 2.21952739 |
| 77 | Poor coordination (HP:0002370) | 2.20779673 |
| 78 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20177895 |
| 79 | Abnormal eating behavior (HP:0100738) | 2.19555354 |
| 80 | Hyperglycemia (HP:0003074) | 2.19532568 |
| 81 | Ketoacidosis (HP:0001993) | 2.18651481 |
| 82 | Postural instability (HP:0002172) | 2.15639682 |
| 83 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14205895 |
| 84 | Clonus (HP:0002169) | 2.12967517 |
| 85 | Hemiparesis (HP:0001269) | 2.12557951 |
| 86 | Papilledema (HP:0001085) | 2.12211376 |
| 87 | Amyloidosis (HP:0011034) | 2.12069711 |
| 88 | Poor speech (HP:0002465) | 2.08855496 |
| 89 | Acanthocytosis (HP:0001927) | 2.08543659 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.08294940 |
| 91 | Alacrima (HP:0000522) | 2.08159880 |
| 92 | Progressive neurologic deterioration (HP:0002344) | 2.07925876 |
| 93 | Hypomagnesemia (HP:0002917) | 2.07603503 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 2.07118576 |
| 95 | Abnormality of the renal medulla (HP:0100957) | 2.05704766 |
| 96 | Thyroid carcinoma (HP:0002890) | 2.05026041 |
| 97 | Akinesia (HP:0002304) | 2.03640583 |
| 98 | Symptomatic seizures (HP:0011145) | 2.03097372 |
| 99 | Pheochromocytoma (HP:0002666) | 2.01935018 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 2.01284064 |
| 101 | Bile duct proliferation (HP:0001408) | 1.99330084 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 1.99330084 |
| 103 | Scanning speech (HP:0002168) | 1.99237791 |
| 104 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98406498 |
| 105 | Lower limb muscle weakness (HP:0007340) | 1.97131730 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.96466273 |
| 107 | Frequent falls (HP:0002359) | 1.95256198 |
| 108 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94870826 |
| 109 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.94230898 |
| 110 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.94230898 |
| 111 | Cerebral hypomyelination (HP:0006808) | 1.93765610 |
| 112 | Agitation (HP:0000713) | 1.92678549 |
| 113 | Clumsiness (HP:0002312) | 1.92012819 |
| 114 | Delusions (HP:0000746) | 1.91904409 |
| 115 | Broad foot (HP:0001769) | 1.91826944 |
| 116 | Choreoathetosis (HP:0001266) | 1.91804695 |
| 117 | Axonal loss (HP:0003447) | 1.91459754 |
| 118 | Hammertoe (HP:0001765) | 1.91114038 |
| 119 | Torticollis (HP:0000473) | 1.90931703 |
| 120 | Megalencephaly (HP:0001355) | 1.90707184 |
| 121 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90132075 |
| 122 | Abnormality of the common coagulation pathway (HP:0010990) | 1.89958375 |
| 123 | Oligodactyly (hands) (HP:0001180) | 1.89950222 |
| 124 | Fetal akinesia sequence (HP:0001989) | 1.89877408 |
| 125 | Choroideremia (HP:0001139) | 1.89425089 |
| 126 | Blue irides (HP:0000635) | 1.89410664 |
| 127 | Drooling (HP:0002307) | 1.88615429 |
| 128 | Excessive salivation (HP:0003781) | 1.88615429 |
| 129 | Postaxial hand polydactyly (HP:0001162) | 1.86965558 |
| 130 | CNS hypomyelination (HP:0003429) | 1.86932293 |
| 131 | Nemaline bodies (HP:0003798) | 1.86446207 |
| 132 | Dialeptic seizures (HP:0011146) | 1.86137852 |
| 133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.84851442 |
| 134 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84087779 |
| 135 | Conjunctival hamartoma (HP:0100780) | 1.83152184 |
| 136 | Steatorrhea (HP:0002570) | 1.82839332 |
| 137 | Posterior subcapsular cataract (HP:0007787) | 1.81787359 |
| 138 | Male pseudohermaphroditism (HP:0000037) | 1.80115649 |
| 139 | Hyperventilation (HP:0002883) | 1.79962707 |
| 140 | Dyskinesia (HP:0100660) | 1.79661195 |
| 141 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.79625874 |
| 142 | Hypobetalipoproteinemia (HP:0003563) | 1.78577687 |
| 143 | Difficulty running (HP:0009046) | 1.78145051 |
| 144 | Abnormality of macular pigmentation (HP:0008002) | 1.77985015 |
| 145 | Epileptic encephalopathy (HP:0200134) | 1.77711731 |
| 146 | Focal motor seizures (HP:0011153) | 1.76940209 |
| 147 | Sclerocornea (HP:0000647) | 1.76827354 |
| 148 | Male infertility (HP:0003251) | 1.76755095 |
| 149 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75974703 |
| 150 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75963021 |
| 151 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.75895077 |
| 152 | Methylmalonic acidemia (HP:0002912) | 1.75695411 |
| 153 | Dysostosis multiplex (HP:0000943) | 1.75601148 |
| 154 | Broad-based gait (HP:0002136) | 1.75067875 |
| 155 | Widely spaced teeth (HP:0000687) | 1.74407395 |
| 156 | Muscle fiber inclusion bodies (HP:0100299) | 1.73304555 |
| 157 | Cystic liver disease (HP:0006706) | 1.73071355 |
| 158 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.72751919 |
| 159 | Limb dystonia (HP:0002451) | 1.72375270 |
| 160 | Absence seizures (HP:0002121) | 1.72221232 |
| 161 | Mutism (HP:0002300) | 1.71521203 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.70632154 |
| 163 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.70506673 |
| 164 | Anxiety (HP:0000739) | 1.70177450 |
| 165 | Neuroendocrine neoplasm (HP:0100634) | 1.70087476 |
| 166 | Facial diplegia (HP:0001349) | 1.69867198 |
| 167 | Postaxial foot polydactyly (HP:0001830) | 1.68144501 |
| 168 | Increased circulating renin level (HP:0000848) | 1.67639591 |
| 169 | Abnormal drinking behavior (HP:0030082) | 1.66532291 |
| 170 | Polydipsia (HP:0001959) | 1.66532291 |
| 171 | Confusion (HP:0001289) | 1.66503347 |
| 172 | Hypokalemic alkalosis (HP:0001949) | 1.66497845 |
| 173 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.66197539 |
| 174 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.66037983 |
| 175 | Aplasia of the phalanges of the hand (HP:0009802) | 1.66037983 |
| 176 | Aplasia involving bones of the extremities (HP:0009825) | 1.66037983 |
| 177 | Spontaneous abortion (HP:0005268) | 1.65770820 |
| 178 | Distal sensory impairment (HP:0002936) | 1.65098474 |
| 179 | Abnormality of salivation (HP:0100755) | 1.65024706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.02959285 |
| 2 | CASK | 3.21611222 |
| 3 | KSR2 | 2.93427005 |
| 4 | OXSR1 | 2.80878149 |
| 5 | ERBB4 | 2.49080905 |
| 6 | LATS1 | 2.43613214 |
| 7 | MAPKAPK5 | 2.41893366 |
| 8 | EPHB1 | 2.40916609 |
| 9 | MAP3K9 | 2.38431780 |
| 10 | TAOK3 | 2.29695924 |
| 11 | PLK2 | 2.24375010 |
| 12 | FGFR2 | 2.24352763 |
| 13 | MST4 | 2.09431796 |
| 14 | PRKD3 | 2.08152404 |
| 15 | PAK6 | 2.08145562 |
| 16 | PKN1 | 2.04738368 |
| 17 | BCR | 1.96474025 |
| 18 | NTRK1 | 1.95676642 |
| 19 | INSRR | 1.95528760 |
| 20 | MET | 1.93666471 |
| 21 | ERBB3 | 1.82546229 |
| 22 | WNK4 | 1.67585713 |
| 23 | SGK223 | 1.66730427 |
| 24 | SGK494 | 1.66730427 |
| 25 | MARK1 | 1.62185405 |
| 26 | MAP3K12 | 1.61143465 |
| 27 | SGK2 | 1.54356944 |
| 28 | DYRK2 | 1.53916389 |
| 29 | LATS2 | 1.52215211 |
| 30 | FRK | 1.52204752 |
| 31 | OBSCN | 1.49495516 |
| 32 | MAP3K13 | 1.47159436 |
| 33 | CSNK1G2 | 1.47059580 |
| 34 | MAP3K2 | 1.46320672 |
| 35 | WNK3 | 1.38868700 |
| 36 | MAP3K6 | 1.37178216 |
| 37 | KSR1 | 1.33366444 |
| 38 | CSNK1G3 | 1.33012187 |
| 39 | TRIM28 | 1.32563977 |
| 40 | CSNK1G1 | 1.29033003 |
| 41 | MUSK | 1.28322654 |
| 42 | CSNK1A1L | 1.25221114 |
| 43 | ARAF | 1.18149763 |
| 44 | MINK1 | 1.14495669 |
| 45 | CAMKK2 | 1.12758881 |
| 46 | EIF2AK3 | 1.12671828 |
| 47 | MARK2 | 1.08458751 |
| 48 | CDK19 | 1.08293568 |
| 49 | PBK | 1.04767246 |
| 50 | YES1 | 1.03284045 |
| 51 | EPHA4 | 1.02845607 |
| 52 | RET | 1.02508776 |
| 53 | WNK1 | 1.02223327 |
| 54 | MAPK15 | 1.02154975 |
| 55 | PAK3 | 1.02013471 |
| 56 | UHMK1 | 1.01938429 |
| 57 | CAMK2B | 1.01402810 |
| 58 | BMPR1B | 1.01061644 |
| 59 | LIMK1 | 1.00635937 |
| 60 | ABL2 | 1.00381825 |
| 61 | FER | 0.99708623 |
| 62 | PTK2B | 0.98995124 |
| 63 | MAPK13 | 0.98495995 |
| 64 | RAF1 | 0.97184168 |
| 65 | NLK | 0.96914996 |
| 66 | CAMK1G | 0.96741909 |
| 67 | PNCK | 0.92961151 |
| 68 | SGK3 | 0.92470669 |
| 69 | LRRK2 | 0.91960754 |
| 70 | PHKG2 | 0.90228573 |
| 71 | PHKG1 | 0.90228573 |
| 72 | GRK5 | 0.89791387 |
| 73 | CAMK1D | 0.89624344 |
| 74 | DYRK1A | 0.89260191 |
| 75 | NEK6 | 0.88607560 |
| 76 | HIPK2 | 0.87497812 |
| 77 | MAP3K4 | 0.87494950 |
| 78 | PDPK1 | 0.86827332 |
| 79 | RIPK4 | 0.84572467 |
| 80 | CAMK2D | 0.83628012 |
| 81 | PRKCG | 0.83290658 |
| 82 | BLK | 0.82729496 |
| 83 | FGR | 0.82036304 |
| 84 | CAMK2A | 0.80880948 |
| 85 | CDK5 | 0.75506540 |
| 86 | FGFR1 | 0.75374130 |
| 87 | CCNB1 | 0.74700125 |
| 88 | STK3 | 0.74224075 |
| 89 | NTRK2 | 0.72970844 |
| 90 | EIF2AK1 | 0.72757444 |
| 91 | CAMK2G | 0.72561353 |
| 92 | BRAF | 0.71729644 |
| 93 | TYRO3 | 0.71487995 |
| 94 | PRKCH | 0.71362221 |
| 95 | FES | 0.70410699 |
| 96 | NTRK3 | 0.70311597 |
| 97 | STK38L | 0.69464622 |
| 98 | SGK1 | 0.69074626 |
| 99 | PINK1 | 0.67629563 |
| 100 | PRKAA2 | 0.67568080 |
| 101 | EPHA3 | 0.66975570 |
| 102 | GRK1 | 0.66398802 |
| 103 | TRPM7 | 0.65774581 |
| 104 | DYRK1B | 0.65631252 |
| 105 | MAP3K1 | 0.64739500 |
| 106 | STK24 | 0.64129909 |
| 107 | MAP2K4 | 0.63003742 |
| 108 | MAP2K7 | 0.62895382 |
| 109 | PRKD1 | 0.62122676 |
| 110 | DMPK | 0.61779750 |
| 111 | ACVR1B | 0.60602727 |
| 112 | BMPR2 | 0.60490495 |
| 113 | DAPK2 | 0.60367519 |
| 114 | BCKDK | 0.59890095 |
| 115 | PRKCE | 0.58119310 |
| 116 | MOS | 0.58108829 |
| 117 | PIK3CG | 0.57829903 |
| 118 | PDGFRB | 0.57357093 |
| 119 | PDK1 | 0.56536415 |
| 120 | NEK1 | 0.52882714 |
| 121 | CSK | 0.52668330 |
| 122 | PRKAA1 | 0.52473946 |
| 123 | TEC | 0.52156745 |
| 124 | ERBB2 | 0.50991945 |
| 125 | PRKCQ | 0.49705567 |
| 126 | MAP4K2 | 0.48441300 |
| 127 | ADRBK1 | 0.48004509 |
| 128 | PIK3CA | 0.47013542 |
| 129 | CDK14 | 0.43343694 |
| 130 | ROCK2 | 0.43337680 |
| 131 | JAK2 | 0.42986596 |
| 132 | TNIK | 0.42937624 |
| 133 | ADRBK2 | 0.42884587 |
| 134 | MELK | 0.42522115 |
| 135 | PRKG1 | 0.42135227 |
| 136 | MAPK12 | 0.41820352 |
| 137 | TAOK1 | 0.41321300 |
| 138 | PRKACB | 0.39087259 |
| 139 | STK11 | 0.38640694 |
| 140 | SIK1 | 0.38575393 |
| 141 | CDK15 | 0.37567494 |
| 142 | PRKCZ | 0.37329238 |
| 143 | CSNK1D | 0.36791614 |
| 144 | CDK18 | 0.36344750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.25491367 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.75988863 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.66265600 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51681422 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.49044018 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.44131019 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.34605952 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.31135983 |
| 9 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.25454832 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.23275077 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20113583 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.18846259 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.18380022 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.00515366 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86465618 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.63014189 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58480568 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55788493 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52045086 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51819586 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51575133 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50754728 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48075895 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43688637 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.35666469 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35298695 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29939536 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26763588 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22055922 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21222744 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21033597 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20237416 |
| 33 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.15725977 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14302077 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12616942 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.12080066 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11701003 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09816334 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07651805 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07545192 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07032162 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05998275 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.04066826 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02144784 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01437154 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.01360653 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00178015 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98284735 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97755478 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96932529 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96678551 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96634448 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92609622 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89001804 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.88128937 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.87691829 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87449413 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87099893 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86955054 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85467232 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.84553069 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82825855 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81327976 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81263493 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.78134972 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77970605 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77441520 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75960204 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72437270 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72303760 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71798828 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71506927 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71087386 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.69492248 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69156995 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68396881 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67565020 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.67196759 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67165127 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66493531 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66426018 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.66096890 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66076603 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.65662669 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.65027822 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63419343 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.63305204 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63296982 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.62535165 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62408860 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61338026 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.60302870 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60124078 |
| 94 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59754845 |
| 95 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58811204 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57365547 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.56705646 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56572108 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54539373 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54377314 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54148429 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54066847 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53951157 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53600495 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53410824 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53305266 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52421206 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49666126 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48888044 |
| 110 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48727963 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48416390 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48187971 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.47988050 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47359250 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47102805 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46776298 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46431864 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45186144 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.44152599 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43946511 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.43763167 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43717449 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43480284 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42298960 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40082351 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.39806801 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39407924 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.38822192 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37687487 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.34994318 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34588547 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32785136 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32452524 |
| 134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31741635 |
| 135 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31462677 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31073527 |
| 137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31018705 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30588062 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30417370 |

